文献速递精神分裂症与精神病性障碍会诊联络精神医学

精神分裂症与乳腺癌发病风险的荟萃分析

Association of Schizophrenia With the Risk of Breast Cancer Incidence: A Meta-analysis.
PubMed 文献 · JAMA Psychiatry · 2018-01-01

结果显示精神分裂症女性乳腺癌发病率显著高于一般人群(SIR 1.31,95%CI 1.14-1.50,P<.001),但研究间异质性显著(I²=89%),预测区间宽泛(0.81-2.10)。作者建议对精神分裂症女性加强乳腺癌防治。

要点

  • 精神分裂症女性乳腺癌发病风险较一般人群升高(SIR 1.31)。
  • 研究间异质性显著(I²=89%),预测区间宽泛(0.81-2.10)。
  • 亚组分析显示基线排除乳腺癌病例或样本量不影响关联。

核心结论

  • 精神分裂症女性乳腺癌发病率高于一般女性人群,但纳入研究间存在显著异质性。

研究设计与样本

  • 系统检索PubMed和EMBASE数据库,最终检索于2017年8月15日,纳入报告标准化发病比(SIR)的队列研究。

主要发现

  • 精神分裂症与女性乳腺癌发病风险显著增加相关(SIR 1.31;95%CI 1.14-1.50;P<.001)。
  • 研究间异质性显著(P<.001;I²=89%),预测区间为0.81-2.10,提示未来研究可能显示风险降低。
  • 亚组分析显示基线是否排除乳腺癌病例或研究样本量对关联无显著影响。

关键数值与推荐

  • 主要结局指标为精神分裂症女性 compared with 一般人群或无精神分裂症女性的乳腺癌SIR。

临床怎么用

  • 对精神分裂症女性应加强乳腺癌的预防和筛查工作。
  • 临床需关注精神分裂症女性乳腺癌风险升高,但应结合异质性解读个体风险。

局限性

  • 纳入研究间存在显著异质性(I²=89%),预测区间宽泛提示结果稳定性有限。
  • 原文未报告其他局限性信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Patients with schizophrenia are considered to have many risk factors for the development of cancer. However, the incidence of breast cancer in women with schizophrenia compared with the general population remains uncertain. OBJECTIVE: To perform an updated meta-analysis to evaluate the association between schizophrenia and the risk of breast cancer. DATA SOURCES: A systematic search of the PubMed and EMBASE databases was conducted using the search terms schizophrenia, schizophrenic, psychosis, combined with breast and cancer, tumor, neoplasm, or carcinoma. The final literature search was performed on August 15, 2017. STUDY SELECTION: Cohort studies reporting the standardized incidence ratio (SIR) for the risk of breast cancer in women with schizophrenia compared with the general population. DATA EXTRACTION AND SYNTHESIS: The meta-analysis adhered to Meta-analysis of Observational Studies in Epidemiology and the Cochrane Handbook for Systematic Reviews of Interventions. Data extraction was performed independently. A random-effects model was used to pool the results, and a recently proposed prediction interval was calculated to describe the heterogeneity. MAIN OUTCOMES AND MEASURES: The SIR for the risk of breast cancer in women with schizophrenia compared with the general population or those without schizophrenia. RESULTS: Twelve cohorts including 125 760 women were included in this meta-analysis. The results of the meta-analysis showed that schizophrenia was associated with a significantly increased risk of breast cancer incidence in women (SIR, 1.31; 95% CI, 1.14-1.50; P < .001), with significant heterogeneity (P < .001; I2 = 89%). Substantial between-study variance was also suggested by the wide prediction interval (0.81-2.10), which indicated that it is possible that a future study will show a decreased breast cancer risk in women with schizophrenia compared with the general population. The subgroup analysis results showed that the association was not significantly affected by whether breast cancer cases were excluded at baseline or the sample size of the included studies. CONCLUSIONS AND RELEVANCE: The incidence of breast cancer in women with schizophrenia is higher than that of the general female population. However, significant heterogeneity exists among the included studies. Women with schizophrenia deserve intensive prevention and treatment of breast cancer.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Zhuo C, Triplett PT. Association of Schizophrenia With the Risk of Breast Cancer Incidence: A Meta-analysis. JAMA Psychiatry. 2018. PMID: 29516094. doi:10.1001/jamapsychiatry.2017.4748

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。